FBXO16 and ovarian cancer: In FBXO16-deficient ovarian cancer cells, depleting hnRNPL not only inhibited cell proliferation, clonogenic survival, and cell invasion, but also repressed the activation of signaling pathways such as RAS, EMT, and MAPK, which were closely related to the molecular mechanism and biological function of FBXO16.